A handful of research centers around the world are studying autoimmune dementia, a rare and often misdiagnosed form of cognition loss that can be treated. (The Guardian)
Two analyses — one of Framingham Heart Study participants, the other of the Atherosclerosis Risk in Communities cohort — found a strong, bidirectional relationship between dementia and epilepsy. (Neurology)
Migraine was tied to cryptogenic ischemic stroke in people 18 to 49 years old, a case control study showed. (Annals of Neurology)
Relapsing-remitting multiple sclerosis patients treated with autologous hematopoietic stem cell transplant (AHSCT) had a higher likelihood of maintaining no evidence of disease activity for 3 years than those treated with alemtuzumab (Lemtrada). (Journal of Neurology, Neurosurgery & Psychiatry)
The National Multiple Sclerosis Society issued AHSCT recommendations, noting the best candidates likely are people under age 50 who have had MS for less than 10 years. (JAMA Neurology)
The FDA declined to approve a zolmitriptan transdermal microneedle patch (Qtrypta) for acute migraine due to inconsistent drug exposure levels across multiple clinical trials, said manufacturer Zosano Pharma.
The AHEAD study of Eisai’s investigational drug BAN2401 in people with preclinical Alzheimer’s disease is ramping up cautiously, despite COVID-19. (NPR)
Medicare beneficiaries with Alzheimer’s disease in rural areas spent more time in nursing homes, less time in the community, and had shorter survival time than their urban counterparts. (JAMA Network Open)
Emergency department and inpatient costs for functional neurological disorders totaled more than $1.2 billion a year. (JAMA Neurology)
Head trauma, electrical burns, and hobbies that involved using lead upped the risk of developing sporadic amyotrophic lateral sclerosis (ALS), as did working in mechanics, painting, or construction. (Muscle and Nerve)
“Technical Difficulties in the Time of COVID”: a pediatric neurologist penned poetry for the pandemic. (Neurology)
Source: MedicalNewsToday.com
